By this, downstream effectors of PI3k (i.e. pAKT, GSK3β, p70S6K and ribosomal protein S6) are inhibited in various preclinical models like cell lines and xenografts resulting in effective inhibition of tumor proliferation and growth. This evidence concerns the gene PIK3CG and neoplasm.